Novo Nordisks semaglutide (Ozempic for diabetes, Wegovy for obesity) and Eli Lillys dual-agonist tirzepatide (Mounjaro, a related drug that also activates the GIP hormone receptor) have become blockbusters , propelling their companies to record-high market valuations ( [15] ) ( [16] )
I'm 62 years old, my metabolism is shot
Centers for Medicare & Medicaid Services (CMS)
Peer review Peer review information Nature Communications thanks Jing Yang, Vinayak Khodade and the other anonymous reviewer(s) for their contribution to the peer review of this work
Author contributions AB: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writingoriginal draft, Writingreview and editing
weight loss* Zepbound mimics two natural hormones, GLP-1 and GIP, to help you feel full and reduce hunger